secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2025-04-29T23:59:59+00:00
Accession:  0001708599-25-000048
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics enters ATM facility for up to $13.3M common stock sale
--------------------------------------------------------------------------

- Entered Capital on Demand Sales Agreement with JonesTrading for at-the-market offering of up to $13,270,500 in common stock.
- JonesTrading will receive 3.0% commission on gross sales; company also reimburses up to $50,000 in legal expenses.
- Sales will occur on NYSE American or other trading markets at the company's direction; no minimum obligation to sell.
- Updated description of capital stock filed as Exhibit 4.1 to reflect recent certificate of designations.
- Proceeds intended for general corporate purposes; offering registered on Form S-3 (File No. 333-286340).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000048/0001708599-25-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000048/ser-20250425.htm
  HTML page:      https://secwatch.observer/filing/0001708599-25-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer